Progressive Investment Management’s Quest Diagnostics DGX Stock Holding History

Progressive Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,388	Closed	-$2.24M	–	50
2016 Q4	$2.24M	Sell	24,388 -618	-2%	-$53.3K	2.05%	27
2016 Q3	$2.12M	Sell	25,006 -1,648	-6%	-$138K	1.97%	31
2016 Q2	$2.17M	Sell	26,654 -1,058	-4%	-$80.6K	2.1%	25
2016 Q1	$1.98M	Sell	27,712 -900	-3%	-$60.4K	2.01%	27
2015 Q4	$2.04M	Sell	28,612 -82	-0.3%	-$5.51K	2.17%	20
2015 Q3	$1.76M	Buy	+28,694	New	+$2.01M	2.04%	24

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Progressive Investment Management's DGX Position: Q1 2017 in Review

Progressive Investment Management sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 24,388 shares — an estimated $2.24M sold.

Progressive Investment Management first reported a position in DGX in Q3 2015 and held it in 6 quarters. The position peaked at $2.24M in Q4 2016. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

Progressive Investment Management reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
Progressive Investment Management sold 24,388 Quest Diagnostics shares in Q1 2017, an estimated $2.24M.
Progressive Investment Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 6 quarters.
Progressive Investment Management's Quest Diagnostics position peaked at $2.24M in Q4 2016.
614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Progressive Investment Management's 13F filing for Q1 2017, filed 25 Apr 2017.